Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.21 USD | +1.66% | +4.54% | +103.76% |
Financials (USD)
Sales 2024 * | 358M | Sales 2025 * | 414M | Capitalization | 2.13B |
---|---|---|---|---|---|
Net income 2024 * | 83M | Net income 2025 * | 127M | EV / Sales 2024 * | 5.97 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.15 x |
P/E ratio 2024 * |
26.1
x | P/E ratio 2025 * |
17.1
x | Employees | 624 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.47% |
Latest transcript on ADMA Biologics, Inc.
1 day | +1.66% | ||
1 week | +4.54% | ||
Current month | +41.26% | ||
1 month | +48.55% | ||
3 months | +74.43% | ||
6 months | +131.99% | ||
Current year | +103.76% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 47 | 06-06-01 |
Compliance Officer | 37 | 10-12-31 | |
Skyler Bloom
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 73 | 12-07-23 |
Bryant Fong
BRD | Director/Board Member | 51 | 12-04-30 |
Steven Elms
CHM | Chairman | 60 | 06-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +9.17% | - | |
0.01% | 9 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 9.21 | +1.66% | 3,629,093 |
24-05-16 | 9.06 | -0.44% | 2,114,551 |
24-05-15 | 9.1 | -0.66% | 3,130,697 |
24-05-14 | 9.16 | +4.21% | 3,768,594 |
24-05-13 | 8.79 | -0.23% | 5,220,555 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.76% | 2.13B | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- ADMA Stock